HS
IGMS

HighVista Strategies’s IGM Biosciences IGMS Stock Holding History

HighVista Strategies’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,446
Closed -$1.02M – 91
2021
Q3 		$1.02M Buy
15,446
+4,965
+47% +$380K 0.67% 52
2021
Q2 		$872K Buy
10,481
+1,560
+17% +$116K 0.62% 32
2021
Q1 		$684K Sell
8,921
-3,033
-25% -$276K 0.51% 42
2020
Q4 		$1.05M Buy
11,954
+2,537
+27% +$178K 0.67% 25
2020
Q3 		$695K Buy
9,417
+3,271
+53% +$194K 0.51% 21
2020
Q2 		$449K Buy
+6,146
New +$373K 0.37% 32

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighVista Strategies's IGMS Position: Q4 2021 in Review

HighVista Strategies sold out of IGM Biosciences (IGMS) in Q4 2021, closing a stake of 15,446 shares — an estimated $1.02M sold.

HighVista Strategies first reported a position in IGMS in Q2 2020 and held it in 6 quarters. The position peaked at $1.05M in Q4 2020. 87 funds tracked by Wall St. Rank hold IGMS as of Q4 2021.

  • HighVista Strategies reported no remaining IGM Biosciences position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 15,446 IGM Biosciences shares in Q4 2021, an estimated $1.02M.
  • HighVista Strategies first reported a position in IGM Biosciences in Q2 2020 and held it in 6 quarters.
  • HighVista Strategies's IGM Biosciences position peaked at $1.05M in Q4 2020.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.